NCT03873584

Brief Summary

The treatment of anemia depends on its cause. Patients with underlying iron-deficient anemia should be treated or referred to a specialist (eg gynecologist, gastroenterologist) for treatment.deficiency anemia are global health problems and common medical conditions seen in everyday clinical practice. Iron is vital for biological functions, such as breathing, energy production, DNA synthesis, and cell proliferation. Iron deficiency refers to the reduction of iron stores and precedes the occurrence of iron deficiency anemia. Iron deficiency anemia is a more severe condition in which low levels of iron are associated with anemia and the presence of small cellular red blood cells.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2022

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 12, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 13, 2019

Completed
3.5 years until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
Last Updated

February 16, 2023

Status Verified

February 1, 2023

Enrollment Period

1.1 years

First QC Date

March 12, 2019

Last Update Submit

February 14, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Fatigue Symptoms in Iron Deficiency Anaemia

    Fatigue Assessment Scale (FAS) rating

    3 months

Secondary Outcomes (1)

  • Hemoglobin levels

    3 months

Interventions

FatigueOTHER

Iron deficiency anemia with fatigue symptoms

Eligibility Criteria

Age16 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

2400 iron deficient patients with fatigue symptoms who are treated with iron succinylate.

You may qualify if:

  • yers
  • Iron deficiency anemia
  • Treatment with iron succinylate
  • Fatigue symptoms
  • Informed Consent
  • Compliance with study procedures

You may not qualify if:

  • Anemia caused by other parameters (non-iron-deficiency)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

AnemiaAnemia, Iron-DeficiencyFatigue

Condition Hierarchy (Ancestors)

Hematologic DiseasesHemic and Lymphatic DiseasesAnemia, HypochromicIron DeficienciesIron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms
0

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 12, 2019

First Posted

March 13, 2019

Study Start

September 1, 2022

Primary Completion

September 30, 2023

Study Completion

September 30, 2023

Last Updated

February 16, 2023

Record last verified: 2023-02